We have located links that may give you full text access.
Endotheliopathy of Trauma in Children: The Association of Syndecan-1 with Injury and Poor Outcomes.
Journal of Trauma and Acute Care Surgery 2023 December 9
BACKGROUND: The contribution of the endothelium to trauma-induced coagulopathy has not been thoroughly investigated in injured children.
METHODS: This is a prospective cohort study of children (age < 18) who presented with a potentially severe injury to an academic pediatric trauma center. Syndecan-1 level was collected on arrival and 24 hours following hospital arrival. Children were categorized as injured vs uninjured based on results of trauma evaluation. Demographics, injury characteristics, vital signs, and clinical labs were recorded. A composite clinical outcome was defined as death or blood product transfusion within 24 hours of hospital arrival. Statistical tests determined the impact of injury characteristics and therapeutics on syndecan-1 levels and assessed for associations between syndecan-1 level and outcomes.
RESULTS: 121 subjects were included in the analysis: 96(79%) injured and 25(21%) uninjured. There were no differences between groups in age (median[IQR] 11 years[4-14]), sex, or race. The injured cohort had median(IQR) ISS of 16(9-21), 75% blunt mechanism, 26% were transfused within 6 hours, 3% 24-hour mortality, and 6% in-hospital mortality. Median(IQR) syndecan-1 level on admission was significantly higher in injured vs uninjured cohort (44[21-75] vs 25[17-42]; p = 0.04). Admission base deficit was significantly correlated with syndecan-1 level (r = 0.8, p < 0.001); no association with traumatic brain injury or injury mechanism was seen. Children with elevated syndecan-1 on admission had significantly increased odds of poor outcome; every 10 ng/mL increase in syndecan-1 was associated with 10% increased odds of death or transfusion (p < 0.001). Transfusion with any blood product was associated with a significant decrease in syndecan-1 from arrival to 24 hours (delta syndecan-1 = -17[-64- -5] vs -8[-19-2]; p < 0001).
CONCLUSION: Elevated admission syndecan-1 level, suggestive of endotheliopathy, was associated with shock and poor outcomes in pediatric trauma. Larger cohort studies are required to fully describe the complexities of TIC and investigate the benefit of therapies targeting endotheliopathy in children.
LEVELS OF EVIDENCE: Level 3, Prospective study.
METHODS: This is a prospective cohort study of children (age < 18) who presented with a potentially severe injury to an academic pediatric trauma center. Syndecan-1 level was collected on arrival and 24 hours following hospital arrival. Children were categorized as injured vs uninjured based on results of trauma evaluation. Demographics, injury characteristics, vital signs, and clinical labs were recorded. A composite clinical outcome was defined as death or blood product transfusion within 24 hours of hospital arrival. Statistical tests determined the impact of injury characteristics and therapeutics on syndecan-1 levels and assessed for associations between syndecan-1 level and outcomes.
RESULTS: 121 subjects were included in the analysis: 96(79%) injured and 25(21%) uninjured. There were no differences between groups in age (median[IQR] 11 years[4-14]), sex, or race. The injured cohort had median(IQR) ISS of 16(9-21), 75% blunt mechanism, 26% were transfused within 6 hours, 3% 24-hour mortality, and 6% in-hospital mortality. Median(IQR) syndecan-1 level on admission was significantly higher in injured vs uninjured cohort (44[21-75] vs 25[17-42]; p = 0.04). Admission base deficit was significantly correlated with syndecan-1 level (r = 0.8, p < 0.001); no association with traumatic brain injury or injury mechanism was seen. Children with elevated syndecan-1 on admission had significantly increased odds of poor outcome; every 10 ng/mL increase in syndecan-1 was associated with 10% increased odds of death or transfusion (p < 0.001). Transfusion with any blood product was associated with a significant decrease in syndecan-1 from arrival to 24 hours (delta syndecan-1 = -17[-64- -5] vs -8[-19-2]; p < 0001).
CONCLUSION: Elevated admission syndecan-1 level, suggestive of endotheliopathy, was associated with shock and poor outcomes in pediatric trauma. Larger cohort studies are required to fully describe the complexities of TIC and investigate the benefit of therapies targeting endotheliopathy in children.
LEVELS OF EVIDENCE: Level 3, Prospective study.
Full text links
Related Resources
Trending Papers
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease.Rheumatology 2024 April 17
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Albumin: a comprehensive review and practical guideline for clinical use.European Journal of Clinical Pharmacology 2024 April 13
Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists.Mayo Clinic Proceedings 2024 April
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app